Literature DB >> 16033530

Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.

S M Mansour Haeryfar1, David M Conrad, Brucel Musgrave, David W Hoskin.   

Abstract

Thy-1 (CD90) expressed by mouse T cells is known to have signal transducing properties, but the ability of Thy-1 to enhance cytotoxic T lymphocyte (CTL) development is not well understood. Here we show that stimulation of mouse T cells with monoclonal antibodies (mAb) to CD3, CD28 and Thy-1 (clone G7), which were coimmobilized on polystyrene microbeads, resulted in a greater proliferative response than stimulation with only anti-CD3 and anti-CD28 mAb, indicating that Thy-1 cross-linking enhanced T cell receptor/CD28-driven T cell activation. Consistent with this finding, Thy-1 blockade with a soluble nonactivating anti-Thy-1 mAb (clone 30-H12) inhibited anti-CD3-induced proliferation of CD4+ and CD8+ T cells, and the induction of cytotoxic effector cells in a dose-dependent fashion. Interleukin-2 synthesis and CD25 expression were also impaired by Thy-1 blockade. The inhibitory effect involved a defect at or before the level of protein kinase C activation because the addition of phorbol ester ablated the anti-Thy-1-mediated inhibition of anti-CD3-induced T cell activation. The CTL that were induced in the presence of blocking anti-Thy-1 mAb adhered to target cells but showed reduced expression of granzyme B and perforin. In contrast, Fas ligand expression and function was not affected by Thy-1 blockade. We conclude that Thy-1 signalling promotes the in vitro generation of CTL that kill in a granule-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033530     DOI: 10.1111/j.1440-1711.2005.01342.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  9 in total

1.  Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses.

Authors:  Lisa A Mannik; Ian Chin-Yee; Shayan Sharif; Luc Van Kaer; Terry L Delovitch; S M Mansour Haeryfar
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

2.  Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium.

Authors:  Giorgia Jurisic; Maria Iolyeva; Steven T Proulx; Cornelia Halin; Michael Detmar
Journal:  Exp Cell Res       Date:  2010-06-23       Impact factor: 3.905

3.  Thy-1 mRNA destabilization by norepinephrine a 3' UTR cAMP responsive decay element and involves RNA binding proteins.

Authors:  Melissa D LaJevic; Sujatha P Koduvayur; Veronique Caffrey; Rhonna L Cohen; Donald A Chambers
Journal:  Brain Behav Immun       Date:  2010-04-20       Impact factor: 7.217

4.  Naïve Primary Mouse CD8+ T Cells Retain In Vivo Immune Responsiveness After Electroporation-Based CRISPR/Cas9 Genetic Engineering.

Authors:  Petra Pfenninger; Laura Yerly; Jun Abe
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

5.  Selection and Evaluation of Specific Single Chain Antibodies against CD90, a Marker for Mesenchymal and Cancer Stem Cells.

Authors:  Bahareh Moazen; Amir Zarrinhaghighi; Foroogh Nejatollahi
Journal:  Rep Biochem Mol Biol       Date:  2018-10

Review 6.  Targeting cancer stem cells by using the nanoparticles.

Authors:  In-Sun Hong; Gyu-Beom Jang; Hwa-Yong Lee; Jeong-Seok Nam
Journal:  Int J Nanomedicine       Date:  2015-09-10

7.  Impaired specific CD8 T cell response with aging is not due to decreased expression of CD90 on TCR transgenic T cells.

Authors:  Jiu Jiang; Erin Fisher; Donna M Murasko
Journal:  Immun Ageing       Date:  2013-08-19       Impact factor: 6.400

Review 8.  Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting.

Authors:  Bing Lu; Xiaojia Huang; Jingxin Mo; Wei Zhao
Journal:  Front Pharmacol       Date:  2016-04-12       Impact factor: 5.810

9.  Neuronal CD200 Signaling Is Protective in the Acute Phase of Ischemic Stroke.

Authors:  Abdullah Al Mamun; Conelius Ngwa; Shaohua Qi; Pedram Honarpisheh; Saumil Datar; Romana Sharmeen; Yan Xu; Louise D McCullough; Fudong Liu
Journal:  Stroke       Date:  2021-08-06       Impact factor: 10.170

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.